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Abstract 
In contrast with the common detection of T cells that recognize MHC, CD1a, CD1c or CD1d 
proteins, CD1b autoreactive T cells have been difficult to isolate in humans. Here were report the 
development of polyvalent complexes of CD1b proteins and carbohydrate backbones 
(dextramers) and their use to identify CD1b autoreactive T cells from human donors. Activation 
is mediated by  T cell receptors binding to CD1b-phospholipid complexes, which is sufficient 
to activate autoreactive responses to CD1b-expressing cells. Using mass spectrometry and T cell 
responses to scan through the major classes of phospholipids, we identified phosphatidylglycerol 
(PG) as the immunodominant lipid antigen. T cells did not discriminate the chemical differences 
that distinguish mammalian PG from bacterial PG. Whereas most models of T cell recognition 
emphasize TCR discrimination of differing self and foreign structures, CD1b autoreactive T cells 
recognize lipids with dual self and foreign origin. PG is rare in the the cellular membranes that 
carry CD1b proteins. However, bacteria and mitochondria are rich in PG, so these data point to a 
more general mechanism of immune detection of infection- or stress-associated lipids.  
 
Significance statement 
Peptides are known to be targets of autoreactive T cells that can cause autoimmune diseases. 
Here we show that human T cells recognize self lipids displayed on the surface of cells by CD1b 
proteins. A particular lipid that is recognized by CD1b autoreactive cells, phosphatidylglycerol, 
is present in mammalian mitochondria and in bacteria. Therefore, these data define a 
phospholipid autoantigen that is released during mitochondrial stress and bacterial infection.  
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\body 
Introduction 
Whereas most studies of the human T cell response have focused on peptide antigens 
bound to MHC class I or II molecules, human CD1 proteins represent a parallel system of 
antigen display that allows T cells to recognize and respond to lipids. Like MHC II proteins, 
human CD1 antigen presenting molecules (CD1a, CD1b, CD1c, CD1d) are expressed at high 
density on the surface of professional antigen presenting cells (APCs), such as myeloid dendritic 
cells (DCs), Langerhans cells and B cells (1). CD1 proteins can capture self lipids in the 
endoplasmic reticulum or the secretory pathway, and the cytoplasmic tails of CD1b, CD1c and 
CD1d proteins mediate transport to lysosomes for antigen capture at low pH (2). However, 
unlike MHC proteins, the inner surface of CD1 clefts are lined by hydrophobic, rather than polar 
or charged amino acids, so that there is almost no overlap in the chemical nature of antigens 
displayed by MHC and CD1 proteins. Thus, the spectrum of natural antigens for T cells is 
broader than previously thought, creating a situation in which lipids might be developed as the 
basis for detecting or activating human T cells.  
In addition to CD1d, humans and most other mammals express CD1a, CD1b and CD1c 
proteins, which are known as group 1 CD1 proteins. Prior work using human T cell clones (3-7) 
and the recently developed human CD1a, CD1b and CD1c tetramers (8-10) have demonstrated 
the existence of mycobacteria-reactive T cells, including polyclonal T cells with stereotyped 
TCRs, known as germline-encoded mycolyl lipid-reactive (GEM) T cells (11) and LDN5-like T 
cells (12). Currently, nearly all foreign antigens presented by CD1b, including mycolic acid, 
glucose monomycolate, glycerol monomycolate and sulfoglycolipids, are selectively synthesized 
by Mycobacterium tuberculosis and related mycobacterial species. Whether or not CD1b 
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functions more broadly in human T cell responses to other types of bacteria is unknown. To 
address the breadth of pathogens recognized by CD1b-mediated T cells, we studied human T cell 
responses to pathogenic Salmonella, Staphylococcus and Brucella species. CD1b tetramers have 
recently been proven to markedly enhance the rate of detection and recovery of CD1b-reactive T 
cells (8, 11, 12). However, tetramers are not usually used for antigen discovery because they 
require that homogenous antigen preparations be loaded onto MHC or CD1 proteins. That is, two 
or more arms of the tetramer must be loaded with the same or similar antigen, which is usually 
needed to create a multimeric ligand with sufficient avidity to bind TCRs.  
However, we reasoned that bacterial lipid mixtures could be screened for T cell response 
using higher order CD1b multimers formed on dextran polymer backbones, which are known as 
dextramers. This strategy is based on the premise that the higher valence can increase the chance 
that two or more of the CD1b proteins capture equivalent lipids to create TCR binding epitopes. 
Whereas mycobacteria express at least 119 classes of lipids defined by Lipid Maps and the 
MycoMass dataset (13), Staphylococcus, Salmonella and Brucella species produce a much 
simpler lipid envelope whose content is dominated by membrane phospholipids, which are polar 
and elute in methanol from normal phase silica columns. Further, prior efforts to discover lipid 
antigens for CD1 proteins have isolated antigens from methanol eluents of silica columns (4, 14). 
Therefore, use of methanol eluents from bacteria represented a semi-targeted approach that 
seems to enrich for amphipathic molecules that posses CD1 binding properties. This screening 
approach succeeded in reproducibly detecting human  T cells responding to all three bacterial 
species, thereby expanding the scope of pathogens recognized by the CD1b system. Surprisingly, 
studies aimed at solving the chemical structure of the lipid antigens showed that the optimal 
molecular targets were phospholipids that are synthesized both in mammalian cells and 
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pathogens. Further, recognition of self lipids by T cells was accompanied by autoreactivity to 
CD1b expressed on human cells. We show that the molecular basis of self and foreign lipid 
antigen recognition required TCR binding to CD1b-phospholipid complexes, but data 
pointed away from differences in self and foreign lipid structure as the determinant of T cell 
response. Instead, these studies showed that CD1b-presented antigens are rare in in the 
membranes from which CD1b proteins capture self lipids, but are highly abundant in bacteria.  
 
Results and Discussion 
To isolate T cells that recognize microbial antigens derived from pathogens other than 
mycobacteria, we treated CD1b proteins with lipid extracts from Staphylococcus aureus, 
Brucella melitensis, and Salmonella Typhimurium. CD1b-lipid complexes were conjugated to 
dextran polymer backbones (dextramers) with an approximate valence of 10. Mock-treated or 
bacterial lipid-treated dextramers were used to stain PBMC isolated from healthy blood bank 
donors. Microbial lipid-treated CD1b dextramer+ T cells could be detected in the blood at low 
frequency, comparable to that of naive, peptide-specific T cells or glucose monomycolate-
specific T cells (~1 in 105). After flow cytometric sorting and expansion of cells in culture, 
polyclonal T cell lines from two donors were derived that stained with bacterial lipid-loaded 
CD1b dextramers (Figure 1a). CD1b dextramer staining was bright, and no staining was seen 
using CD1a dextramers as a control. Usign this method, T cell lines could be generated in 
response to lipids from all three species of bacteria and in each of two donors (A25, BC8) 
(Figure 1b). In functional assays of T cell response, IFN- ELISPOT showed that S. aureus, B. 
melitensis, and S. Typhimurium lipids stimulated cytokine responses when APCs (K562 cells) 
were transfected to express CD1b but not in response to K562 cells expressing CD1a (Figure 
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2a). Thus, CD1b dextramers represent a new and reliable method to detect human T cells that 
respond to CD1b, demonstrating clear reactivity to lipids from three non-mycobacterial species.  
Surprisingly, all four T cell lines also showed clear responses to CD1b-transfected K562 
cells in the absence of bacterial extract, although bacterial lipids did increase IFN- production in 
some cases (Figure 2a). This finding was unexpected because the T cell lines were derived using 
bacterial lipids. More generally, the finding was notable because studies over the past 20 years 
have produced little evidence for T cell autoreactivity to CD1b proteins. CD1b-mediated T cell 
responses to defined antigens can be generated through in vitro immunization with self or foreign 
antigens (3, 7, 15), and a mouse TCR recognizes human CD1b (16). However, CD1b-mediated 
human T cell autoreactivity to endogenously expressed lipids in human cells is limited to a few 
clones (17, 18), in contrast to the large number of known MHC-, CD1a-, CD1c- and CD1d-
autoreactive clones. Further, in systematic analyses of CD1 autoreactivity using large panels of T 
cell clones (19, 20) or in polyclonal T cells (20), T cell autoreactivity to CD1b was very low or 
undetectable under conditions in which CD1a, CD1c and CD1d autoreactivity are prominent. We 
confirmed the lack of autoreactivity of another CD1b-glucose monomycolate (GMM) specific 
cell line, known as LDN5, under conditions in which the four newly derived T cell lines showed 
strong autoreactivity.  Conversely, we demonstrate the lack of recognition of GMM by these 
autoreactive cell lines (Figure S1). Together, these experiments demonstrated that autoreactivity 
and CD1b-GMM specificity are non-overlapping T cell specificities and that CD1b 
autoreactivity is not a general feature of T cells that recognize foreign antigens presented by 
CD1b.  
The T cell lines were named after the donor and antigen source, and in three of the four 
lines (BC8Staphylococcus, A25Salmonella, A25Staphylococcus), autoreactivity to CD1b could 
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be confirmed using a second APC type, the B cell lymphoblastoid cell line C1R, transfected with 
CD1b (C1R.CD1b). In a multiplex cytokine array of 38 effector molecules, CD1b-dependent 
secretion of IL-2, IL-4, IL-8, IL-13, TNF, IFN-, MIP-1, MIP-1, oncostatin M (OSM), 
CXCL13 (B lymphocyte chemoattractant, BLC), GM-CSF, sTNF-RII was demonstrated (Figure 
2b). However, upon stimulation with C1R.CD1b, the line BC8Staphylococcus did not produce 
cytokines in concentrations that were more than twice higher than seen with mock-transfected 
C1R cells. Bacterial lipid mixtures might activate T cells via many receptors, but we observed 
TCR downregulation and CD25 upregulation on nearly all cells, which is characteristic of TCR-
mediated signals (Figure 2c). Whereas these mechanistic experiments were performed with two 
types of CD1b transfectants, we also observed a strong reponse to monocyte derived DCs, which 
meaningfully model the function of natural CD1b-expressing APCs (Figure S2 and S3). 
Collectively, these data provide clear evidence for the existence of human T cells that are 
autoreactive to CD1b proteins.  
Next we sought to understand why T cells isolated using lipids from three differing 
bacterial species could also recognize CD1b proteins expressed on cells that were not exposed to 
bacterial lipids. This might be explained if TCRs directly bind CD1b without regard to the 
loaded lipid, similar to a recently identified mechanism by which a CD1a autoreactive TCR 
binds an unliganded facet of the CD1a surface (21). However, lipid-independent recognition was 
unlikely since bacterial lipids strongly augmented dextramer staining of all four T cell lines 
(Figure 1b). Interestingly, one subtle aspect of dextramer staining patterns hinted that 
endogenous self lipid antigens can also mediate TCR binding to CD1b. Two T cell lines 
(BC8Staphylocccus, BC8Brucella) showed higher staining for mock-loaded CD1b dextramers as 
compared with CD1a dextramers (Figure 1b) while two other T cell lines stained with nearly 
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identical intensity with mock and bacterial lipid treated CD1b dextramers. This pattern could be 
explained if mock-loaded tetramers produced in mammalian cells carry lipid autoantigens. 
Therefore, a potentially important implication of these results is the possible existence of 
endogenous self lipid antigens for the CD1b system that are recognized in a cross-reactive 
manner by T cells that can also detect bacterial lipids.  
To test this hypothesis, highly purified or synthetic phospholipids, including phosphatidic 
acid (PA), phosphatidylinositol (PI), phosphatidylserine (PS), phosphatidylcholine (PC), 
phosphatidylglycerol (PG) and phosphatidylethanolamine (PE) were used to probe their ability to 
mediate CD1b dextramer binding to T cells. Although it is less abundant in mammalian cells, we 
also tested lysophosphatidic acid (LPA) because it is an antigen or permissive ligand in the 
CD1d and CD1a systems. Lines A25Salmonella and BC8Staphylococcus generated distinct 
patterns of T cell response to structurally related phospholipids (Figure 3a). Both lines showed 
reactivity towards PA, but not LPA, showing that two fatty acids are required for recognition. 
The two lines showed markedly differing staining with PI and PC but both stained with multiple 
lipids and showed very strong staining with PG. Mammalian cells and bacteria both produce PA 
and PG, so these lipids can be considered antigens with dual self and foreign origin, which might 
explain the mixed patterns of recognition of untreated and bacterial lipid-treated dextramers 
(Figure 1b) or CD1b proteins expressed on mammalian cells (Figure 2a). Further, because 
many genera of bacteria other than the three studied here overexpress PG as compared to 
mammalian cells, this lipid might represent a general target for bacterial recognition by T cells.  
To more directly test this hypothesis, methanol eluates from S. aureus and S. 
Typhimurium were subjected to nanoelectrospray ionization mass spectrometry in the negative 
mode. We detected strong signals corresponding to the expected mass of the [M-H]- ion of PG in 
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S. aureus (m/z 714.4) and S. Typhimurium (m/z 733.4), with detailed structures confirmed by 
collision-induced dissociation mass spectrometry (CID-MS) (Figure 3b, Supplemental Figure 
S4). The dominant form of PG that was detected in S. Typhimurium contains a C17:1 and a C16 
acyl chain, and the dominant form of PG in S. aureus contains a C17 and a C15 acyl chain, 
which is consistent with published data (22). Thus, PG is present in the methanol eluates loaded 
onto CD1b dextramers, and it is notable that ions corresponding to PG were the dominant 
phospholipid identified in these lipid preparations (Figure 3b). This finding is consistent with 
prior reports that PG is abundant in many bacteria, and that it is a quantitatively dominant 
phospholipid in S. aureus (23) and S. Typhimurium (24).  
To potentially explain the higher dextramer binding (Figure 1) and T cell activation 
(Figure 2) upon treatment with bacterial lipids, we considered whether subtle differences in PG 
structure could control reactivity. In fact, there are known, systematic differences in fatty acid 
content, position (sn1 or sn2) and chirality (R or S) of the glycerol head group in mammalian and 
bacterial PGs. In particular, fatty acyl units of bacterial but not mammalian PGs have methyl 
branching or cyclopropyl groups, and such substitutions have been shown to promote recognition 
of lipids in some (6, 25-27) but not in all (28) situations. CD1b dextramers loaded with either 
pure synthetic PGs matching the common mammalian form or stereoisomers present in 
Corynebacterium glutamicum, or natural PG from Listeria monocytogenes or Escherichia coli all 
showed comparable dextramer staining intensity, which largely ruled out this fine specificity 
hypothesis (Figure 3c-d).  
However, a second possible basis for self-foreign discrimination is the known difference 
between PG concentrations in mammalian and bacterial cells. PG is relatively scarce in 
mammalian cells, comprising between 1 and 5% of the total phospholipid content in mammalian 
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tissues or cultured cells (29). Further, unlike other mammalian phospholipids, PG is synthesized 
in mitochondria, where it is used in cardiolipin biosynthesis and maintains an organelle-specific 
distribution pattern (30, 31). PG cannot be detected in the membranes that comprise CD1b+ 
subcellular compartments, including the endoplasmic reticulum and Golgi apparatus, and is 
present in trace amounts in the plasma membrane (32). In contrast, PG is highly abundant in 
bacterial membranes. For example, in S. Typhimurium, E. coli, S. aureus and B. subtilis it 
accounts for 18, 19, 58, and 70% of the total phospholipids respectively (23, 24, 33). Thus, PG 
can be considered a dual self and foreign molecule, but its presence at high levels in bacterial 
membranes represents a plausible means of detection as a foreign antigen, representing a general 
signature of microbial infection.  
Line A25Salmonella showed a pattern of staining in which each of several phospholipids 
mediated dextramer binding in a defined hierarchy (Figure 3a). This pattern might have been 
caused by true cross-reactivity of one TCR with several phospholipids, or instead by multiple 
TCRs within an oligoclonal T cell line, each of which specifically recognizes one phospholipid 
type. To distinguish these possibilities and formally identify the receptor mediating response, we 
cloned two TCRs from A25Salmonella, which were named PG10 and PG90 based on the 
recognition of PG by the T cell line they were derived from. The PG10 TCR was comprised of 
TRAV13-1, TRAJ8, TRBV4-1, and TRBJ2-3, and PG90 expressed TRAV26-1, TRAJ13, 
TRBV7-8, and TRBJ2-2 TCR gene segments (Figure 4a). The TCRs were retrovirally 
transduced into Jurkat clone 76 cells that lack endogenousTCR  and  chains (34). Jurkat.PG10 
and Jurkat.PG90 cells recognized C1R cells transduced with CD1b, but not wild type C1R cells, 
formally establishing that these two TCRs mediate CD1b autoreactivity (Figure 4a).  
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To determine antigen specificity of these clonal TCRs, we carried out staining 
experiments with CD1b tetramers. Whereas dextramers outperformed tetramers when loaded 
with mixed lipids, tetramers were adequate when loaded with pure lipid ligands (Figure 4). 
Tetramers were mock loaded and thus contain a mixture of endogenous self phospholipids, or 
were loaded with defined glycerophospholipids, or were loaded with known CD1b ligands that 
are not glycerophospholipids (sphingomyelin, ganglioside T1b, sulfatide, and glucose 
monomycolate). The resulting staining patterns supported several key conclusions. First, both 
Jurkat.PG10 and Jurkat.PG90 stained with more than one CD1b-phospholipid tetramer, 
demonstrating true antigen cross-reactivity to phospholipids for single TCRs. Second, despite 
distinct TCR gene usage, the pattern of reactivity observed for PG10 and PG90 was highly 
similar in both transfectants and the parental A25Salmonella line. The two TCRs have minor 
differences in antigen specificity: the strongest staining was seen in response to PG, followed by 
PA or PS, but only PG10 stained with PI-loaded tetramers. Thus, the observed autoreactivity of 
A25Salmonella is likely mediated by two or more distinct TCRs that bind CD1b-PG complexes, 
with detectable but lower avidity for CD1b complexes made with other membrane 
phospholipids.  
More generally, we conclude that human  TCRs mediate CD1b autoreactivity and do 
so through recognition of CD1b bound to self lipids, including PG and PA. The phospholipids 
PC and PI were known to bind to CD1b, but thought to have a chaperone-like function instead of 
interacting with TCRs or providing activation signals (35, 36). As the concept of  T cell 
autoreactivity to CD1b emerges, the particular hierarchies of lipids that mediate CD1b-TCR 
binding provides some initial clues on the origin of autoantigens as well as testable hypotheses 
regarding a cellular mechanism of CD1b autoreactivity. Combining results obtained with soluble 
13 
 
CD1b produced by 293T cells and CD1b expressed on K562 or C1R cells, dextramer and 
tetramer staining (Figures 1, 3a, 3c, 4) and T cell activation (Figures 2, 4) depend on whether 
CD1b proteins display a homogeneous or heterogeneous cohort of self lipids and the extent to 
which these can either promote or block TCR binding to CD1b. Interestingly, mock-loaded 
CD1b tetramers show detectable staining on both Jurkat.PG10 (MFI=371) and Jurkat.PG90 
(MFI=489). Furthermore, the non-glycerophospholipid ligands did not enhance this staining and 
in some instances caused reduced staining compared to mock-loaded tetramers, raising the 
possibility that some CD1b bound ligands may be inhibitory (Figure 4b). Therefore, similar to 
models recently proposed for CD1a (20, 21), cellular autoreactivity is plausibly controlled by the 
ratio of activating to blocking ligands on the surface, rather than the failure to recognize self 
lipids and the introduction of foreign lipids during infection.  
Overall PG is much more abundant in bacteria than in mammalian cells.  Therefore,  our 
favored hypothesis is that bacterial infection represents a means for introducing antigens into the 
host.  However, prior studies also show that in mammalian cells, PG is present at low 
concentrations and is thought to be exclusively synthesized in mitochondria.  Thus, PG may 
normally  be largely inaccessible to CD1b in a steady state, but appear in settings that cause 
mitochondrial stress. Therefore, exposure to PG-rich bacteria or activation of stress pathways 
that release rare self antigens both become candidate mechanisms of phospholipid-mediated T 
cell activation.  
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Materials and Methods 
Antigens 
Staphylococcus aureus was cultured in Brain-Heart Infusion broth, and Salmonella 
Typhimurium was cultured in Luria Broth. Brucella melitensis human isolate, strain X10017283-
001 (CVI) was cultured in tryptic soy broth. Lipid extracts were prepared by extracting bacterial 
pellet with chloroform/methanol 1:2 (V:V) for two hours at room temperature, followed by 
chloroform/methanol 2:1 (V:V). Fractions were generated that are enriched for neutral lipids, 
polar lipids, and charged lipids by loading total lipid extracts on disposable silica columns 
(Alltech, 10 mg) and eluting with chloroform, acetone, and methanol, respectively. C32 glucose 
monomycolate was purified from Rhodococcus equi. Listeria monocytogenes C17 C15 PG was 
purified as described. C18:1 C16 RR PG and C18:1 C16 RS PG, which are commonly found in 
Corynebacterium glutamicum, were synthesized as described (27). The following commercially 
available lipids were used: PS from brain (Avanti 840032c), C16 C18:1 PC (Avanti 850475c), 
C16 C18:2 PI (Avanti 840044c), C16 C18:1 PA (Avanti 840857), C18:1 LPA (Avanti 857130c), 
synthetic C16 C18:1 PE (Avanti 850757c), synthetic PG C18 C18:1, which is commonly found 
in mammalian cells (Avanti 840503), E. coli C16 C17 PG (Avanti 841188p), N-nervonoyl-D-
erythro-sphingosylphosphorylcholine (SM) (Avanti), Mono-Sulfo Galactosyl() Ceramide 
(C24:1 Sulfatide) (Avanti), Trisialoganglioside (GT1b) was obtained from Sigma-Aldrich.  
Flow cytometry 
For the generation of dextramers, CD1a and CD1b monomers produced in the human cell line 
HEK 293T (NIH tetramer facility) were loaded with antigens and assembled into phycoerythrin- 
or allophycocyanin-labeled dextramers as described (8, 9). Dextramers were incubated with cells 
for 30 minutes at room temperature prior to adding monoclonal antibodies for an additional 30 
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minutes on ice. For tetramers, DNA encoding for the ectodomain of human CD1b fused to a C-
terminal BirA and hexa-His tag, or 2m, was cloned into the vector pHLsec and expressed by 
transient transfection of mammalian HEK293S.GnTI cells (37). CD1b was purified using 
immobilized metal affinity chromatography and gel filtration, and biotinylated with BirA 
enzyme (Avidity) as per manufacturer’s protocol. Lipid-loaded biotinylated monomers were 
tetramerized by the addition of streptavidin-PE (BD Pharmingen) at a 4:1 molar ratio. For 
loading, lipid antigens were prepared in 0.5% tyloxapol in Tris-buffered saline pH 8.0 and 
loaded into CD1b at a 6:1 lipid:protein molar ratio at room temperature overnight. Flow 
cytometry data were pre-gated for lymphocytes based on forward and side scatter. The following 
antibodies were used: CD3-FITC (SK7, BD biosciences) CD3-allophycocyanin (UCHT1, 
eBioscience and Becton Dickinson), CD69-phycoerythrin, (FN50, Becton Dickinson), and 
CD25-FITC (BC96, Biolegend). Cells were analysed on a FACS Canto II or LSRFortessa, and 
sorted on a FACSAria III (Becton Dickinson). Data were analysed using FlowJo (Treestar Inc.). 
T cell lines and T cell assays 
Leukoreduction collars from random blood bank donations were obtained from the Brigham and 
Women’s Hospital Specimen Bank. Sorted CD1b dextramer+ T cells were stored overnight in 
medium (10) containing 0.2 ng/ml IL-15 and plated the next day at 1000 cells/well in round 
bottom 96-well plates containing 2 x 105 irradiated allogeneic peripheral blood mononuclear 
cells, 4 x 104 irradiated Epstein-Barr virus transformed B cells, 30 ng/ml anti CD3 antibody 
OKT3 and 1 ng/ml of IL-2 which was added on day 2 of the culture. After 2 weeks, CD1b 
dextramer+ cells were sorted and expanded again. For ELISPOT assays, co-cultures of 2 x 104 
APCs and 3 x 103 T cells were incubated for 16 h in a Multiscreen-IP filter plate (96 wells; 
Millipore) coated according to the manufacturer's instructions (Mabtech). An unpaired two-tailed 
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t test was used for comparisons of two groups. For Luminex multiplex cytokine assays, 1 x 105 T 
cells and 1 x 105 CD1b expressing or non-expressing C1R cells were mixed, or alternatively, 
cells were stimulated with PMA and ionomycin, and supernatants were collected after 24 hours.  
TCR cloning and transfer 
TCR  and  chains were determined by PCR and Sanger sequencing as described previously 
(12). An antibody against TRBV4-1 (ZOE, Beckman Coulter) was used to sort a subpopulation 
of the T cell line A25Salmonella. Cell lines expressing αβTCRs were generated as previously 
described (37). Briefly, Jurkat-76 cells were transduced with pMIGII vector containing full 
length PG10 or PG90 TCR  and  chains, separated by a 2A-linker. For co-culture assays, 
Jurkat-76 T cells lines were either cultured with wild type C1R cells or with C1R cells 
expressing CD1b (3 x 104 of each cell line) for 6–12 h in round-bottom 96-well plates and their 
activation status measured by flow cytometry to detect CD69 upregulation.  
17 
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Figure legends 
Fig. 1 Generation of T cell lines that recognize bacterial lipids presented by CD1b 
(a) T cells from donor A25 that bind to CD1b dextramers loaded with Salmonella Typhimurium 
lipids were enriched by multiple rounds of FACS sorting and expansion until they reached near-
uniform binding of bacterial lipid extract-loaded CD1b dextramers. (b) Flow cytometric analysis 
of the cell line shown in panel a, as well as a Staphylococcus aureus lipid-specific cell line from 
the same donor, using the indicated CD1 dextramers. Two additional T cell lines were analyzed 
that were specific for Brucella melitensis and Staphylococcus aureus lipids, derived from donor 
BC8. For each T cell line, at least five flow cytometric experiments were performed with similar 
results.  
 
Fig. 2 Bacterial lipid-specific T cells are autoreactive to CD1b proteins on mammalian cells 
Bacterial lipid-specific T cell lines were stimulated with K562 cell lines stably transfected with 
the indicated CD1 isoform (a is CD1a, b is CD1b), with or without exogenously added S. 
Typhimurium (Sal.) or S. aureus (Staph.)  lipids  in an IFN- ELISPOT assay (a) or stimulated 
with mock transfected or CD1b transfected C1R lines in the absence of exogenous antigen, upon 
which supernatants were harvested after 24 hours and analyzed for cytokine content.  (b). In 
panel b, only those cytokines are shown that were produced upon stimulation with C1R.CD1b 
but not upon stimulation with mock transfected C1R cells. In addition to the cytokines shown, 11 
analytes were produced upon stimulation with PMA and ionomycin, but not upon stimulation 
with C1R.CD1b: IL-3, IL-6, IL-9, IL-10, IL-17, IL-22, IL-31, LT- (TNF-), CCL1 (I-309), 
CXCL10 (IP-10), latency-associated peptide (LAP) of TGF-. Production of the following 
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fifteen analytes was tested but not detected in response to C1R.CD1b or PMA and ionomycin: 
Interleukin-1 receptor antagonist (IL-1Ra), IL-5, IL-12, IL-21, IL-25, IFN-, IFN-, April, 
macrophage migration inhibitory factor (MIF), CCL17 (TARC), CXCL1 (Gro-1), soluble 
(s)PD-1, sFas, sFas-L, sTNF-RI. (c) The A25Salmonella T cell line was stimulated with CD1a or 
CD1b-transfected cells for 20 hours prior to flow cytometric analysis of CD25 or CD3 
expression. In a, and c one representative experiment out of three is shown. For b, one 
experiment was performed on the pooled supernatants of triplicate wells. * P<0.05; ** P<0.01; 
NS: not significant.  
 
Fig. 3 Phosphatidylglycerol is a major target of CD1b-autoreactive T cells 
(a) CD1b dextramers were loaded with the major classes of phospholipids and used to stain 
bacterial lipid-specific T cell lines. (b) Negative ions present in the methanol-eluted fractions 
from S. aureus and S. Typhimurium were analyzed by collisional mass spectrometry and 
generated patterns that are consistent with phosphatidylglycerol (PG). (c) The same two cell lines 
that were shown in a were analyzed using CD1b dextramers loaded with PG from mammalian 
and bacterial sources, the structures of which are shown in d. Panels a and c represent one of two 
independent experiments. Even though the branching pattern of fatty acids could not be 
determined directly, S. aureus fatty acids are drawn as anteiso forms because that is the most 
common form for C15 and C17 in this species (22). The C17 fatty acid in S. Typhimurium can 
be C17:1 or cyclopropyl C17 (38).  
 
Fig. 4 Single CD1b autoreactive TCRs recognize multiple phospholipids 
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Two TCRs that were cloned from the A25Salmonella T cell line, named PG10 and PG90, were 
stably transduced into Jurkat cells. (a) The PG10 and PG90 TCR-expressing Jurkat cells were 
incubated overnight with wild type C1R cells or CD1b-transfected C1R cells before they were 
stained with an antibody against CD69. PG10 and PG90-expressing Jurkat cells were stained 
with CD1b tetramers loaded with the indicated lipids (b). Results in b represent one out of four 
independently performed experiments.  
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